var title_f37_23_38256="3 3 2 rule for identifying a difficult airway";
var content_f37_23_38256=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 583px\">",
"   <div class=\"ttl\">",
"    The 3-3-2 rule for identifying a difficult airway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 563px; height: 186px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The spatial relationships depicted here are important determinants of successful direct laryngoscopy. A) The patient can open his/her mouth sufficiently to admit three of his/her own fingers. B) The distance between the mentum and the neck/mandible junction (near the hyoid bone) is the length of three of the patient's fingers. C) The space between the superior notch of the thyroid cartilage and the neck/mandible junction, near the hyoid bone, is the length of two of the patient's fingers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38256=[""].join("\n");
var outline_f37_23_38256=null;
var title_f37_23_38257="CDC BMI for age boys 2 to 20 years";
var content_f37_23_38257=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60784&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60784&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 577px\">",
"   <div class=\"ttl\">",
"    Body mass index-for-age percentiles, boys, 2 to 20 years, CDC growth charts: United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 557px; height: 669px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Developed by the National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion (2000).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38257=[""].join("\n");
var outline_f37_23_38257=null;
var title_f37_23_38258="Abruptio placentae gross";
var content_f37_23_38258=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Abruptio placenta",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 403px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A large retroplacental hematoma derived from rupture of a spiral artery separates the placenta from the underlying uterus and indents the basal plate of the placenta.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Raymond W. Redline, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38258=[""].join("\n");
var outline_f37_23_38258=null;
var title_f37_23_38259="Bivalirudin: Patient drug information";
var content_f37_23_38259=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Bivalirudin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/48/18184?source=see_link\">",
"     see \"Bivalirudin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F141778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Angiomax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F141779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Angiomax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to thin the blood so that clots will not form.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701639",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to bivalirudin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703718",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014792\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fall or crash when you hit your head. Talk with your doctor even if you feel fine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014790\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014791\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11926 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-168C04E0CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38259=[""].join("\n");
var outline_f37_23_38259=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141778\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141779\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014788\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014787\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014792\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014793\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014795\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014790\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014791\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014796\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014797\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?17/48/18184?source=related_link\">",
"      Bivalirudin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_23_38260="Estimation of the sodium deficit in patients with hyponatremia";
var content_f37_23_38260=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Estimation of the sodium deficit in patients with hyponatremia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38260/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38260/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38260/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38260/contributors\">",
"     Michael Emmett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38260/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38260/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/23/38260/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyponatremia represents a relative excess of water in relation to sodium. It can be induced by a marked increase in water intake (primary polydipsia) or, in the great majority of cases, by impaired water excretion resulting from advanced renal failure or from persistent release of antidiuretic hormone (ADH) induced by effective volume depletion, the syndrome of inappropriate ADH secretion (SIADH), thiazide diuretics, adrenal insufficiency, or hypothyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/30/3562?source=see_link\">",
"     \"Causes of hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with true volume depletion and some with SIADH require saline administration to raise the serum sodium. Isotonic saline is typically sufficient in true volume depletion but is ineffective in SIADH where, if saline is given, a hypertonic solution is typically required. The mechanisms responsible for these conclusions are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/34/18986?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of the treatment of hyponatremia\", section on 'Sodium chloride administration'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When treating patients with moderate to severe hyponatremia with saline, formulas have been used to estimate the sodium deficit as a guide to initial therapy and to estimate the effect of a given volume of saline. The utility and limitations of these formulas will be reviewed here. An overview of the treatment of hyponatremia is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/34/18986?source=see_link\">",
"     \"Overview of the treatment of hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SODIUM DEFICIT FORMULA",
"    </span>",
"    &nbsp;&mdash;&nbsp;When saline is given to treat hyponatremia, the quantity of sodium required to achieve the desired elevation in the serum sodium concentration can be estimated from the product of the serum sodium deficit per liter and the total body water (TBW):",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Sodium deficit &nbsp;= &nbsp;TBW &nbsp;x &nbsp;(desired serum Na &nbsp;- &nbsp;actual serum Na)",
"   </p>",
"   <p>",
"    Although sodium itself is restricted to the extracellular fluid, changes in the serum sodium concentration reflect changes in osmolality and are distributed through the total body water. TBW is estimated as lean body weight times 0.5 for women and 0.6 for men.",
"   </p>",
"   <p>",
"    Another formula &mdash; the Adrogue-Madias formula &mdash; was devised to predict the rise in serum sodium in hyponatremic patients after an intravenous saline infusion. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Adrogue-Madias formula'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of issues related to the sodium deficit formula deserve emphasis. Because of these limitations, the main use of the formula is to estimate the initial rate of sodium administration. Serial measurements of the serum sodium concentration are required to assess the impact of therapy, beginning at two to three hours and then every three to four hours while active treatment is being given.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The formula estimates the amount of sodium that needs to be given without water to raise the serum sodium to the desired value. It overestimates the true effect since sodium will be given with water as isotonic or hypertonic saline. In addition, the estimate of total body water may not be accurate since lean body weight cannot be directly measured.",
"     </li>",
"     <li>",
"      The formula does not include any isosmotic losses that may also be present. As an example, a patient with severe diarrhea may lose five liters of isosmotic fluid and then become hyponatremic by drinking and retaining three liters of water. The formula estimates the amount of sodium required to counteract the dilutional effect of the three liters of free water; there will still be a two liter isosmotic sodium and water deficit.",
"     </li>",
"     <li>",
"      The formula assumes that free water loss does not occur, but this does not apply if the underlying stimulus to ADH release can be corrected as with the treatment of hyponatremia due to true volume depletion (eg, vomiting or diarrhea). In this setting, isotonic saline (sodium concentration 154",
"      <span class=\"nowrap\">",
"       meq/L)",
"      </span>",
"      produces only a minor initial increase in serum sodium concentration of about 1",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      per liter of saline in a normal sized patient. However, restoration of normovolemia will eliminate the hypovolemic stimulus to ADH release, thereby allowing the excess water to be excreted in a maximally dilute urine, which can lead overly rapid correction of the hyponatremia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38260/abstract/1\">",
"       1",
"      </a>",
"      ]. Other settings in which reversal of the underlying stimulus to ADH release can rapidly raise the serum sodium include transient SIADH after surgery and the administration of glucocorticoids in adrenal insufficiency. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/34/18986?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of the treatment of hyponatremia\", section on 'Treat the underlying disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Overly rapid correction of severe hyponatremia (serum sodium concentration usually less than 110 to 115",
"    <span class=\"nowrap\">",
"     meq/L),",
"    </span>",
"    primarily if of more than 48 hours duration, must be",
"    <strong>",
"     avoided",
"    </strong>",
"    since it can lead to a severe and usually irreversible neurologic disorder called the osmotic demyelination syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10074?source=see_link\">",
"     \"Osmotic demyelination syndrome and overly rapid correction of hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Adrogue-Madias formula",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inability of formulas to accurately predict the magnitude of rise in serum sodium after saline therapy was demonstrated in a retrospective study of 62 hyponatremic patients who were treated with hypertonic saline; the mean pretreatment serum sodium was 112",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38260/abstract/2\">",
"     2",
"    </a>",
"    ]. This study used the Adrogue-Madias formula to predict the change in serum sodium per liter of fluid infused [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38260/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;Change in serum Na &nbsp;= &nbsp;(Infusate minus serum Na) &nbsp;",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    &nbsp;(TBW + 1)",
"   </p>",
"   <p>",
"    Ten patients (16 percent) had an increase in serum sodium of more than 12",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    at 24 hours",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    more than 18",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    at 48 hours. The true rate of overly rapid correction may have been higher, since the more recent recommendation is to raise the serum sodium by less than 10",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in the first 24 hours. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/34/18986?source=see_link&amp;anchor=H16#H16\">",
"     \"Overview of the treatment of hyponatremia\", section on 'Avoid overly rapid correction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overly rapid correction was due to a documented water diuresis in four (defined as a low urine osmolality or high urine output). In addition, among patients with a serum sodium concentration below 120",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    the actual increase in serum sodium exceeded the increase predicted by the formula in 74 percent of patients; the average ratio of actual to expected was 1.7 overall and 2.4 in the ten patients who were overly rapid correctors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Use for initial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical use of the sodium deficit formula to determine initial therapy can be illustrated by the following example. The calculations are based upon an estimate of total body water and, as noted above, do not take into account potentially important urinary and extrarenal water losses, which will also raise the serum sodium concentration. As a result, serial monitoring is essential to make certain that the desired effect is achieved.",
"   </p>",
"   <p>",
"    A nonedematous, mildly symptomatic woman who weighs 60 kg (approximately 50 percent of which is water) has a serum sodium concentration of 116",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    The goal is to raise the serum sodium concentration by 6",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in the first 24 hours. The sodium deficit (in meq) for initial therapy can be estimated from the above formula:",
"   </p>",
"   <p>",
"    &nbsp;Sodium deficit &nbsp;= &nbsp; TBW (0.5 &nbsp;x &nbsp;60 L) &nbsp;x &nbsp;desired change in serum sodium (122 - 116) &nbsp;= &nbsp; 180 meq",
"   </p>",
"   <p>",
"    The 180 meq of sodium can be given as 360 mL of hypertonic (3 percent) saline, which contains approximately 500 meq of sodium per liter, or 1 meq of sodium per 2 mL. This volume of hypertonic saline can be given at an initial rate of 15",
"    <span class=\"nowrap\">",
"     mL/h,",
"    </span>",
"    which would be expected to raise the serum sodium concentration at close to the desired rate of 6",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    during the first 24 hours which, as noted above, should be confirmed by serial measurements of the serum sodium, beginning at two to three hours and then every three to four hours while active treatment is being given. Isotonic saline is",
"    <strong>",
"     not",
"    </strong>",
"    used as initial therapy in this setting, since it will have a relatively minor direct effect on the hyponatremia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/34/18986?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of the treatment of hyponatremia\", section on 'Sodium chloride administration'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The serum sodium concentration will increase by one of two mechanisms: retention of the sodium in patients who are hypovolemic; or initial retention of the sodium followed by the excretion of sodium and water in the SIADH. In SIADH, volume regulation is intact and the administered sodium will be excreted in the urine due to the associated volume expansion. It is the water loss induced by excretion of the extra sodium that is responsible for the steady state elevation in the serum sodium concentration in SIADH. The amount of water loss varies inversely with the urine to serum electrolyte ratio. Similar principles apply to the use of a high salt diet or salt supplements for the chronic management of SIADH. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/57/17306?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat\", section on 'Therapies to raise the serum sodium'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Effect of potassium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potassium is as osmotically active as sodium; as a result, giving potassium (usually for concurrent hypokalemia) can raise the serum sodium concentration and serum osmolality in hyponatremic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38260/abstract/1,4-6\">",
"     1,4-6",
"    </a>",
"    ]. Since most of the excess potassium enters the cells, electroneutrality is maintained in one of three ways, each of which will raise the serum sodium concentration:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intracellular sodium moves into the extracellular fluid.",
"     </li>",
"     <li>",
"      Extracellular chloride moves into the cells with potassium; the increase in cell osmolality promotes free water entry into the cells.",
"     </li>",
"     <li>",
"      Intracellular hydrogen moves into the extracellular fluid. These hydrogen ions are buffered by extracellular bicarbonate and to a much lesser degree plasma proteins. This buffering renders the hydrogen ions osmotically inactive; the ensuing fall in extracellular osmolality leads to water movement into the cells.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The net effect is that concurrent administration of potassium must be taken into account when calculating the sodium deficit. This relationship becomes clinically important in the patient with severe diuretic or vomiting-induced hyponatremia who is also hypokalemic.",
"   </p>",
"   <p>",
"    Suppose, for example, that the serum potassium concentration is 2",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    and it is decided to give 400 meq of potassium during the first day. If the patient is a 70 kg man, the total body water will be approximately 40 liters (60 percent of body weight). In this setting, 400 meq distributed through 40 liters will raise the serum sodium concentration by roughly 10",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (and plasma osmolality by 20",
"    <span class=\"nowrap\">",
"     mOsm/kg),",
"    </span>",
"    which is at the upper limit for safe correction. Thus, giving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/57/34711?source=see_link\">",
"     potassium chloride",
"    </a>",
"    alone will correct",
"    <strong>",
"     both",
"    </strong>",
"    the hyponatremia and the hypokalemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38260/abstract/4\">",
"     4",
"    </a>",
"    ]. Giving additional sodium may lead to an overly rapid elevation in the serum sodium concentration.",
"   </p>",
"   <p>",
"    Thus, when calculating the impact of a particular regimen on the serum sodium concentration, one must use the sodium plus potassium concentration of the solution, not simply the sodium concentration. Similar considerations apply to calculating the impact of fluid losses induced by vomiting, diarrhea, or diuretic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38260/abstract/7-13\">",
"     7-13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11175897\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When treating patients with moderate to severe hyponatremia with saline, formulas have been used to estimate the sodium deficit as a guide to initial therapy and to estimate the effect of a given volume of saline. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When saline is given to treat hyponatremia, the quantity of sodium required to achieve the desired elevation in the serum sodium concentration can be estimated from the product of the serum sodium deficit per liter and the total body water (TBW, which is estimated as lean body weight times 0.5 for women and 0.6 for men) (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Sodium deficit formula'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Sodium deficit &nbsp;= &nbsp;TBW &nbsp;x &nbsp;(desired serum Na &nbsp;- &nbsp;actual serum Na)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The above formula overestimates the true effect since sodium will be given with water as isotonic or hypertonic saline. The formula also does not include any isosmotic losses that may also be present. In addition, this formula assumes that free water loss does not occur, but this does not apply if the underlying stimulus to ADH release can be corrected. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Limitations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Another formula, the Adrogue-Madias formula, was devised to predict the rise in serum sodium in hyponatremic patients after an intravenous saline infusion (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Adrogue-Madias formula'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Change in serum Na &nbsp;= &nbsp;(Infusate minus serum Na) &nbsp;",
"      <span class=\"nowrap\">",
"       /",
"      </span>",
"      &nbsp;(TBW + 1)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Like the sodium deficit formula, the Adrogue-Madias formula also performs poorly, particularly in patients who developed a water diuresis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Adrogue-Madias formula'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As a result of the limitations of these formulas, serial monitoring in hyponatremic patients is essential to make certain that the desired effect is achieved. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Use for initial therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Potassium is as osmotically active as sodium; as a result, giving potassium (usually for concurrent hypokalemia) can raise the serum sodium concentration and serum osmolality in hyponatremic patients. Thus, concurrent administration of potassium must be taken into account when calculating the sodium deficit. This relationship becomes clinically important in the patient with severe diuretic or vomiting-induced hyponatremia who is also hypokalemic.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/1\">",
"      Oh MS, Uribarri J, Barrido D, et al. Danger of central pontine myelinolysis in hypotonic dehydration and recommendation for treatment. Am J Med Sci 1989; 298:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/2\">",
"      Mohmand HK, Issa D, Ahmad Z, et al. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2007; 2:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/3\">",
"      Adrogu&eacute; HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342:1581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/4\">",
"      Kamel KS, Bear RA. Treatment of hyponatremia: a quantitative analysis. Am J Kidney Dis 1993; 21:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/5\">",
"      Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med 1986; 81:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/6\">",
"      Fichman MP, Vorherr H, Kleeman CR, Telfer N. Diuretic-induced hyponatremia. Ann Intern Med 1971; 75:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/7\">",
"      Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol 2009; 29:282.",
"     </a>",
"    </li>",
"    <li>",
"     Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.716.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/9\">",
"      Verbalis JG, Goldsmith SR, Greenberg A, et al. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007; 120:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/10\">",
"      Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int 2006; 69:2124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/11\">",
"      EDELMAN IS, LEIBMAN J. Anatomy of body water and electrolytes. Am J Med 1959; 27:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/12\">",
"      Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006; 355:2099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38260/abstract/13\">",
"      Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 8: advanced challenges in resuscitation: section 1: life-threatening electrolyte abnormalities. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102:I217.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2319 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-197.136.42.3-CAC8A55022-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38260=[""].join("\n");
var outline_f37_23_38260=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11175897\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SODIUM DEFICIT FORMULA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Limitations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Adrogue-Madias formula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Use for initial therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Effect of potassium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11175897\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/30/3562?source=related_link\">",
"      Causes of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10074?source=related_link\">",
"      Osmotic demyelination syndrome and overly rapid correction of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/34/18986?source=related_link\">",
"      Overview of the treatment of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/57/17306?source=related_link\">",
"      Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_23_38261="Mometasone (nasal): Drug information";
var content_f37_23_38261=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Mometasone (nasal): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?7/4/7236?source=see_link\">",
"    see \"Mometasone (nasal): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/20/42307?source=see_link\">",
"    see \"Mometasone (nasal): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8775137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Nasonex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8775138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Nasonex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F8775147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Corticosteroid, Nasal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F8775312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Seasonal and perennial allergic rhinitis:",
"     </b>",
"     Intranasal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     U.S. labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Treatment: 2 sprays (100 mcg) in each nostril once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Prevention: 2 sprays (100 mcg) in each nostril once daily beginning 2-4 weeks prior to pollen season",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Canadian labeling (not in U.S. labeling): Initial: 2 sprays (100 mcg) in each nostril once daily; upon symptom control, may consider dose reduction to 1 spray (50 mcg) in each nostril once daily as maintenance therapy.",
"     <b>",
"      Note:",
"     </b>",
"     If adequate symptom control is not achieved with initial dosing, may increase dose to 4 sprays (200 mcg) in each nostril once daily (total daily dose: 400 mcg). Dose reduction is recommended upon symptom control.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of nasal polyps:",
"     </b>",
"     Intranasal: 2 sprays (100 mcg) in each nostril twice daily; 2 sprays (100 mcg) once daily may be effective in some patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rhinosinusitis, adjunctive treatment (acute):",
"     </b>",
"     Intranasal: Canadian labeling (not in U.S. labeling): 2 sprays (100 mcg) in each nostril twice daily; if inadequate symptom control, may increase to 4 sprays (200 mcg) in each nostril twice daily (total daily dose: 800 mcg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rhinosinusitis treatment (acute, mild-to-moderate, uncomplicated):",
"     </b>",
"     Intranasal: Canadian labeling (not in U.S. labeling): 2 sprays (100 mcg) in each nostril twice daily; use beyond 15 days has not been studied.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F8775311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/20/42307?source=see_link\">",
"      see \"Mometasone (nasal): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of seasonal and perennial allergic rhinitis:",
"     </b>",
"     Intranasal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     U.S. labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 2-11 years: 1 spray (50 mcg) in each nostril once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Canadian labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 3-11 years: 1 spray (50 mcg) in each nostril once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rhinosinusitis, adjunctive treatment (acute):",
"     </b>",
"     Intranasal: Canadian labeling (not in U.S. labeling): Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rhinosinusitis treatment (acute, mild-to-moderate, uncomplicated):",
"     </b>",
"     Intranasal: Canadian labeling (not in U.S. labeling): Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F8775313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8775337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, intranasal, as furoate [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nasonex&reg;: 50 mcg/spray (17 g) [contains benzalkonium chloride; delivers 120 sprays]",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F12860277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, intranasal, as furoate [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nasonex&reg;: 50 mcg/spray [contains benzalkonium chloride; delivers 140 sprays]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8775140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F8775315\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Shake well prior to use. Prior to first use, prime pump by actuating 10 times or until fine spray appears; may store for a maximum of 1 week (U.S. labeling recommendations) or 2 weeks (Canadian labeling recommendations) without repriming; if unused for greater than recommended storage period, reprime by actuating 2 times or until fine spray appears. Spray should be administered once or twice daily, at a regular interval.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F8775185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of nasal symptoms of seasonal and perennial allergic rhinitis; prevention of nasal symptoms associated with seasonal allergic rhinitis; treatment of nasal polyps in adults",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional use (not in U.S. labeling): Treatment of mild-to-moderate uncomplicated rhinosinusitis or as adjunctive treatment (with antimicrobials) in acute rhinosinusitis",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F14225201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunct to antibiotics in empiric treatment of acute bacterial rhinosinusitis (ABRS) (Chow, 2012)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F8775195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (17% to 26%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis (8% to 13%), cough (nasal inhalation 7% to 13%), epistaxis (1% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Viral infection (nasal inhalation 8% to 14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, dyspepsia, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Dysmenorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Musculoskeletal pain, myalgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Conjunctivitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Otitis media",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Asthma, nasal irritation, rhinitis, sinusitis, upper respiratory infection, wheezing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Anaphylaxis, angioedema, growth suppression, nasal candidiasis, nasal burning, nasal septal perforation, nasal ulcers, oral candidiasis (nasal inhalation), smell disturbance (rare), taste disturbance (rare)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F8775191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to mometasone or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F8775192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal suppression: When recommended doses are exceeded, or in extremely sensitive individuals, may cause hypercorticism or suppression of hypothalamic-pituitary-adrenal (HPA) axis. Reports consistent with hypercorticism are rare. HPA axis suppression may lead to adrenal crisis. Withdrawal and discontinuation of a corticosteroid should be done slowly and carefully. Fatalities have occurred due to adrenal insufficiency in asthmatic patients during and after transfer from systemic corticosteroids to aerosol steroids; aerosol steroids do",
"     <b>",
"      not",
"     </b>",
"     provide the systemic steroid needed to treat patients having trauma, surgery, or infections.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull;	Delayed wound healing: Avoid nasal corticosteroid use in patients with recent nasal septal ulcers, nasal surgery, or nasal trauma until healing has occurred.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunosuppression: Prolonged use of corticosteroids may also increase the incidence of secondary infection, mask acute infection (including fungal infections), prolong or exacerbate viral infections, or limit response to vaccines. Exposure to chickenpox should be avoided.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infections: Use caution or avoid in patients with active or latent tuberculosis or in patients with untreated fungal, bacterial, or systemic viral infections. Do not use in untreated localized infection involving the nasal mucosa; concurrent antimicrobial therapy should be administered if bacterial infection of the sinuses is suspected/confirmed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular disease: Use with caution in patients with cataracts and/or glaucoma; increased intraocular pressure, open-angle glaucoma, and cataracts have occurred with prolonged use. Consider routine eye exams in chronic users.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Intranasal corticosteroids may cause a reduction in growth velocity in pediatric patients (~1 centimeter per year [range: 0.3-1.8 cm per year] and related to dose and duration of exposure). To minimize the systemic effects of intranasal corticosteroids, each patient should be titrated to the lowest effective dose. Growth should be routinely monitored in pediatric patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Prior to use, the dose and duration of treatment should be based on the risk vs benefit for each individual patient. In general, use the smallest effective dose for the shortest duration of time to minimize adverse events. A gradual tapering of dose may be required prior to discontinuing therapy. There have been reports of systemic corticosteroid withdrawal symptoms (eg, joint/muscle pain, lassitude, depression) when withdrawing inhalation therapy.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F8775199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8775200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8775186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F8775187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal studies following topical and SubQ administration. Hypoadrenalism may occur in infants born to women receiving corticosteroids during pregnancy. Monitor these infants closely after birth. A decrease in fetal growth has not been observed with inhaled corticosteroid use during pregnancy. Inhaled corticosteroids are recommended for the treatment of allergic rhinitis during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F8775189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F8775190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Systemic corticosteroids are excreted in human milk; however, information for mometasone is not available. The use of inhaled corticosteroids is not considered a contraindication to breast-feeding.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F8775339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Nasonex Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mcg/ACT (17 g): $160.08",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10961990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Cobizal (KP);",
"     </li>",
"     <li>",
"      Metaspray (IN);",
"     </li>",
"     <li>",
"      Monitazon (KP);",
"     </li>",
"     <li>",
"      Narinex (KP);",
"     </li>",
"     <li>",
"      Nasative (KP);",
"     </li>",
"     <li>",
"      Nasocobi (KP);",
"     </li>",
"     <li>",
"      Nasomet (PT);",
"     </li>",
"     <li>",
"      Nasonex (AR, AT, AU, BG, CH, CL, CN, CO, CR, CZ, DE, DK, DO, FI, FR, GB, GR, GT, HK, HN, ID, IL, IT, NI, NL, NO, PA, PE, PH, SE, SV, TR, TW, UY, VE);",
"     </li>",
"     <li>",
"      Nasonex Nasal Spray (AU, DE, EE, GB, HK, ID, IE, KP, MY, PH, SG);",
"     </li>",
"     <li>",
"      Nezelex (KP);",
"     </li>",
"     <li>",
"      Rinobudex (EC, PE);",
"     </li>",
"     <li>",
"      Uniclar (CO);",
"     </li>",
"     <li>",
"      Zalconex (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F8775226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May depress the formation, release, and activity of endogenous chemical mediators of inflammation (kinins, histamine, liposomal enzymes, prostaglandins). Leukocytes and macrophages may have to be present for the initiation of responses mediated by the above substances. Inhibits the margination and subsequent cell migration to the area of injury, and also reverses the dilatation and increased vessel permeability in the area resulting in decreased access of cells to the sites of injury.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F8775228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Absorption: Undetectable in plasma",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Chow AW, Benninger MS, Brook I, et al, &ldquo;IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(8):e72-112.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/23/38261/abstract-text/22438350/pubmed\" id=\"22438350\" target=\"_blank\">",
"        22438350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      NAEPP Working Group Report on &ldquo;Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment,&rdquo; National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 05-5236, March 2005. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/health/prof/lung/asthma/astpreg/astpreg_full.pdf\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/health/prof/lung/asthma/astpreg/astpreg_full.pdf",
"      </a>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9778 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-3C5F28D7A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38261=[""].join("\n");
var outline_f37_23_38261=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775137\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775138\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775147\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775312\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775311\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775313\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775337\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12860277\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775140\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775315\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775185\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14225201\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775195\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775191\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775192\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775199\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775200\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775186\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775187\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775189\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775190\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775339\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961990\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775226\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8775228\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9778\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9778|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?7/4/7236?source=related_link\">",
"      Mometasone (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/20/42307?source=related_link\">",
"      Mometasone (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/11/34998?source=related_link\">",
"      Mometasone (oral inhalation): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?7/30/7654?source=related_link\">",
"      Mometasone (oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/6/28773?source=related_link\">",
"      Mometasone (oral inhalation): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?42/46/43748?source=related_link\">",
"      Mometasone (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?12/61/13268?source=related_link\">",
"      Mometasone (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/8/13444?source=related_link\">",
"      Mometasone (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_23_38262="Keratoacanthoma on eyelid";
var content_f37_23_38262=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F52368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F52368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Keratoacanthoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A nodule with central hyperkeratosis is present on the lower eyelid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38262=[""].join("\n");
var outline_f37_23_38262=null;
var title_f37_23_38263="Medullary thyroid cancer: Treatment and prognosis";
var content_f37_23_38263=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Medullary thyroid cancer: Treatment and prognosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38263/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38263/contributors\">",
"     R Michael Tuttle, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38263/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38263/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38263/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38263/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38263/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/23/38263/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with medullary thyroid cancer (MTC) can be cured only by complete resection of the thyroid tumor and any local and regional metastases. For patients with residual or recurrent disease after primary surgery or for those with distant metastases, the most appropriate treatment (surgery, chemotherapy, or radiotherapy) is less clear.",
"   </p>",
"   <p>",
"    This topic review will discuss the role of surgery as primary therapy and the approaches to treating patients with persistent or recurrent MTC after surgery. The approach outlined below is largely in agreement with American Thyroid Association and National Comprehensive Cancer Network (NCCN) guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Recommendations for the timing of thyroidectomy in children with RET mutations are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8872?source=see_link&amp;anchor=H6#H6\">",
"     \"Approach to therapy in multiple endocrine neoplasia type 2\", section on 'Prophylactic thyroidectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Newly diagnosed patients with MTC should be staged both biochemically and radiologically. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link&amp;anchor=H6#H6\">",
"     \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following tests should be performed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measurement of serum calcitonin and carcinoembryonic antigen (CEA), to determine whether they are produced by the tumor and, if so, as a baseline for comparison with results obtained after surgery. Among patients with either sporadic or familial tumors, those with higher preoperative serum calcitonin concentrations have larger tumors and are less likely to have normal serum concentrations after surgery than those with lower preoperative values [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ultrasonography of the neck to assess for local and regional disease. Additional imaging (CT of chest and mediastinum or MRI) is necessary for patients with local lymph node metastases or with preoperative serum basal calcitonin &gt;400",
"      <span class=\"nowrap\">",
"       pg/mL.",
"      </span>",
"     </li>",
"     <li>",
"      Measurement of serum calcium and either plasma fractionated metanephrines or 24-hour urinary excretion of metanephrine and catecholamines to assess for hyperparathyroidism and pheochromocytoma, respectively. This testing should be performed in all patients who have either unknown RET mutation status or a germline RET mutation. In patients with negative RET mutation analysis and no family history of MEN2 related diseases, such testing typically is not required.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some patients with apparently sporadic MTC have unsuspected germline RET mutations (the underlying defect in MEN2) and, therefore, heritable disease. We offer germline RET mutation analysis to all patients with newly diagnosed apparently sporadic MTC. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link&amp;anchor=H1589190#H1589190\">",
"     \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\", section on 'Genetic screening in sporadic MTC'",
"    </a>",
"    .) Germline mutational analysis may be performed preoperatively or postoperatively. Even when performed preoperatively, the results are rarely known prior to surgery. The presence or absence of a germ line mutation has little impact on the initial surgical approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INITIAL SURGICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Total thyroidectomy is the preferred initial treatment for patients with MTC. Up to 30 percent of patients with sporadic MTC and all patients with inherited MTC have bilateral or multifocal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/4\">",
"     4",
"    </a>",
"    ]; in addition, the latter all have premalignant diffuse C cell hyperplasia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link\">",
"     \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=see_link\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MTC usually spreads to the central neck nodes. In one study of 101 consecutive patients with medullary thyroid cancer (and no previous surgery), lymph node metastases to the central compartment were seen in approximately 50 percent of both sporadic (n = 54) and hereditary (n = 47) cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, metastases to the ipsilateral and contralateral jugulocarotid chains were seen in 57 and 28 percent, and 36 and 19 percent of the sporadic and hereditary cases, respectively. In another study, ipsilateral nodes were found in 10 percent of patients with no central node involvement, 77 percent of patients with one to three central nodes, and 98 percent of patients with more than four central nodes; contralateral nodes were found in 4.9 percent of patients with no central nodes, 38 percent of patients with one to nine central nodes, and 77 percent with more than nine central nodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In retrospective series, patient treated with total thyroidectomy with central neck lymph node dissection required fewer reoperations than those receiving lesser procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. As a result, routine dissection of the adjacent nodal tissue in the central compartment from the hyoid bone to the innominate veins and medial to the jugular veins is recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The lateral jugular and mediastinal nodes should be carefully evaluated, followed by modified neck",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mediastinal dissections if positive nodes are identified. Prophylactic neck dissection of the lateral neck in the absence of structurally identifiable disease is not routinely recommended but should be considered if extensive lymph node metastases are identified in the adjacent central neck [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The approach to these surgical procedures is detailed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=see_link\">",
"     \"Surgical treatment of differentiated thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Disfiguring radical neck dissections do not improve prognosis and are not indicated. In the presence of grossly invasive disease, more extended procedures with resection of involved neck structures may be appropriate, but function-preserving approaches are preferred.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;After surgery, the patient should be monitored closely for the development of hypoparathyroidism or injury to either the recurrent or superior laryngeal nerves. These complications are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=see_link&amp;anchor=H15#H15\">",
"     \"Surgical treatment of differentiated thyroid cancer\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Thyroxine therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroxine (T4) therapy should be started immediately after surgery; an appropriate initial dose is 1.6",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    of body weight (ie, approximately 0.075 to 0.15 mg daily). The adequacy of therapy should be evaluated clinically and by measurement of serum thyrotropin (TSH) in one month. The goal of T4 therapy should be to restore and maintain euthyroidism; suppression of serum TSH concentrations to less than normal is not indicated in patients with MTC because C cells are not TSH-responsive. Similarly, adjuvant therapy with radioiodine is not appropriate, because the tumor cells do not concentrate iodine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Serum calcitonin and CEA measurement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum calcitonin and CEA should be measured two to six months after surgery to detect the presence of residual disease. Patients who have normal serum CEA and undetectable serum calcitonin values are considered biochemically cured and have the best prognosis. Among those in one large series who were biochemically cured, the five-year recurrence rate was only 5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The timing of measurement of serum calcitonin after surgery is important, because the serum calcitonin concentration falls slowly in some patients, with the nadir not being reached for several months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/13\">",
"     13",
"    </a>",
"    ]. A high basal serum calcitonin value six or more months after surgery is presumptive evidence of residual disease. Assessment of calcitonin and CEA doubling times provide sensitive markers for progression and aggressiveness of metastatic MTC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12650995\">",
"    <span class=\"h2\">",
"     Assessment for sporadic RET mutation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Demonstration of somatic mutations in MTC tissue samples may be of prognostic value, but it remains unclear how this information would impact clinical management in most cases. Thus, we do not recommend routine testing of tumor samples for somatic RET mutations.",
"   </p>",
"   <p>",
"    In some [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/16-18\">",
"     16-18",
"    </a>",
"    ] but not other [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/19\">",
"     19",
"    </a>",
"    ] studies, tumors with an identifiable RET mutation had a more aggressive course than those without a mutation. For patients with progressive or symptomatic metastatic disease who cannot be treated with surgery or radiotherapy, targeted chemotherapies may be effective. The presence of a somatic RET mutation may predict improved progression-free survival with oral tyrosine kinase inhibitors that target RET, but whether genotype correlates with responsiveness to targeted therapies remains unclear. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/47/23288?source=see_link&amp;anchor=H10576313#H10576313\">",
"     \"Chemotherapy and immunotherapy for medullary thyroid cancer\", section on 'Vandetanib'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H70496114\">",
"    <span class=\"h2\">",
"     Long-term monitoring for patients with undetectable post-operative serum calcitonin",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with undetectable post-operative calcitonin levels and CEA values within the normal reference range, subsequent follow-up should include physical examination and measurement of serum calcitonin and CEA levels twice yearly for two years and then yearly thereafter. We typically obtain a neck ultrasound 6 to 12 months post-operatively to establish a baseline, but additional imaging is not required unless the calcitonin or CEA values rise during follow-up.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF RESIDUAL AND RECURRENT DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9088928\">",
"    <span class=\"h2\">",
"     Persistent hypercalcitoninemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thirty to 55 percent of patients with palpable MTC or nonpalpable but macroscopic MTC who undergo attempted curative resection have persistently high serum calcitonin concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/5,7,12,20,21\">",
"     5,7,12,20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognosis for patients with postoperative hypercalcitoninemia depends primarily upon the patient's age and the extent of disease at the time of initial surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/7,12,22-24\">",
"     7,12,22-24",
"    </a>",
"    ]. In a series of 899 patients with MTC (57 percent sporadic), the 10-year survival in the patients with postoperative hypercalcitoninemia (57 percent of the total group) was 70 percent, compared with 98 percent in patients who were biochemically cured [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/12\">",
"     12",
"    </a>",
"    ]. Younger age at surgery and absence of lymph node involvement were predictive of biochemical cure.",
"   </p>",
"   <p>",
"    Further management depends upon the magnitude of the elevation in the serum calcitonin concentration:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Calcitonin values that are detectable but less than 150",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      two to six months after surgery usually indicate persistent loco-regional disease in the neck. Therefore, neck ultrasound with or without additional cross sectional imaging (CT or MRI of the neck) should be performed to evaluate for the presence of persistent macroscopic metastatic disease. Serum calcitonin and CEA are measured every 6 to 12 months.",
"      <br/>",
"      <br/>",
"      If imaging is positive, meticulous dissection of all local and regional nodal tissue can be considered if there is no evidence of disease outside of the neck or mediastinum. However, outside of centers experienced in managing these patients, only those with overt disease in the neck and no distant metastases should undergo neck surgery. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Surgery for residual disease'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      If imaging is negative and the serum calcitonin values remain stable, neck ultrasound is usually performed on a yearly basis for two to three years, then less often during long-term follow-up. Additional imaging should be considered in patients with rising calcitonin and CEA values with the type and frequency of testing based on both the magnitude and rate of rise of the these biochemical markers.",
"     </li>",
"     <li>",
"      Calcitonin values that remain greater than 150",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      two to six months after surgery increase the likelihood that the patient may have distant metastases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. Therefore, patients with post-operative calcitonin levels that are greater than 150",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      should undergo additional imaging (CT or MRI of neck, chest, and abdomen; bone scan or bone MRI in patients suspected of having skeletal metastases) to identify possible distant metastases.",
"      <br/>",
"      <br/>",
"      The frequency of repeating these various imaging studies will be dependent on the magnitude and rate of rise of the calcitonin and CEA values. As an example, patients with stable post-operative serum calcitonin values in the 150 to 300",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      range are usually followed with yearly neck ultrasound for several years, reserving repeat cross-sectional imaging looking for distant metastases in those patients with rising calcitonin or CEA values.",
"      <br/>",
"      <br/>",
"      18-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) scans are considered only when the serum calcitonin is higher than 500 to 1000",
"      <span class=\"nowrap\">",
"       pg/mL.",
"      </span>",
"      In one report of 28 patients with medullary thyroid cancer, PET had a sensitivity of 78 percent when calcitonin was &gt;1000",
"      <span class=\"nowrap\">",
"       pg/mL,",
"      </span>",
"      but failed to detect disease if calcitonin was &lt;500",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/25\">",
"       25",
"      </a>",
"      ]. Radionuclide imaging with 111-In-pentetreotide, gastrin receptor scintigraphy, or 99m-Tc-dimercaptosuccinic acid, and radionuclide bone imaging can be helpful in selected cases when cross-sectional imaging fails to identify the source of the persistent hypercalcitoninemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/26-28\">",
"       26-28",
"      </a>",
"      ]. Attempted localization of disease by catheterization of the hepatic veins, both internal jugular veins, and the innominate veins, with measurements of serum calcitonin before and after calcium stimulation or laparoscopic examination of the liver is rarely considered and only if these findings would impact clinical management [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Surgery for residual disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, patients with identifiable residual or recurrent MTC were operated on routinely. However, despite routine lymphadenectomy or excision of palpable tumor, their serum calcitonin concentrations often did not fall to normal after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequently, attention was directed toward detection and eradication of microscopic deposits of tumor in an attempt to improve outcome. A 1986 report described the use of microdissection techniques to remove all nodal and perinodal tissue from the neck and upper mediastinum as a reoperation strategy for patients with persistent hypercalcitoninemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/31\">",
"     31",
"    </a>",
"    ]. Four of 11 patients had normal stimulated serum calcitonin concentrations at least two years postoperatively, indicating biochemical cure. In another study, nine of 32 patients (28 percent) undergoing microdissection of the central and bilateral neck compartments were biochemically cured, with minimal perioperative morbidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/32\">",
"     32",
"    </a>",
"    ]. In a subsequent report on 148 patients undergoing reoperation for recurrent or persistent MTC, approximately one-third of patients had long-term (8 to 10 years) eradication of MTC, as assessed by biochemical and imaging studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/33\">",
"     33",
"    </a>",
"    ]. In stage IIIB, selective lymph node resection of enlarging metastatic nodes may be useful to avoid later complications, such as invasion of blood vessels, nerves, etc. However, biochemical cure was obtained in only 13 percent of these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since re-operation is frequently not curative and can be associated with morbidity (ie, hypoparathyroidism, injury to recurrent laryngeal nerve or accessory nerve), we routinely offer an active surveillance observational option to most medullary thyroid cancer patients with persistent, asymptomatic small volume loco-regional disease. These patients are followed with serial cross-sectional imaging at 6 to 12 month intervals and surgical intervention is reserved for patients that have documented structural disease progression. If patients with",
"    <span class=\"nowrap\">",
"     persistent/recurrent",
"    </span>",
"    loco-regional disease, together with their doctors, opt for surgical treatment, they have to realize that biochemical cure after elective surgery will be obtained in only approximately 25 percent of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Radiotherapy for residual disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early studies found no survival benefit from external-beam radiotherapy when patients were matched for age, extent of disease, and surgery with those not given radiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/35\">",
"     35",
"    </a>",
"    ]. However, retrospective analyses have suggested that radiotherapy may prolong the interval until disease progression or recurrence in some patients. In one series, as an example, the 10-year rate of control of local and regional disease was 86 percent in patients with residual microscopic neck disease who received postoperative radiotherapy versus 52 percent in those who were not treated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We currently recommend radiotherapy to the neck and upper mediastinum after primary surgery in patients with extrathyroidal disease or extensive nodal metastases who do not undergo curative dissection. A typical treatment regimen would be 40 Gy (4000 rads) administered in 20 fractions to the cervical, supraclavicular, and upper mediastinal lymph nodes over four weeks, with subsequent booster doses of 10 Gy (1000 rads) in five fractions to the thyroid bed. In addition, radiotherapy is often utilized to palliate painful bone metastases or decrease the risk of fracture from progressive growth of a bone metastasis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TRANSARTERIAL CHEMOEMBOLIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hepatic metastases may benefit from transarterial chemoembolization. In one study of 12 patients using",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    in iodized oil followed by gelfoam, partial responses (lasting a median of 17 months) and stabilization (lasting 24 months) were seen in five and five patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT OF ADVANCED OR RESIDUAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with progressive metastatic disease who cannot be treated by surgery or radiotherapy should be considered candidates for systemic therapy. Treatment with either cytotoxic chemotherapy or biologic response modifiers may provide some benefit. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/47/23288?source=see_link\">",
"     \"Chemotherapy and immunotherapy for medullary thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2736614\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Age at the time of diagnosis has been shown to be an important factor that influences prognosis: the five and 10-year disease-free survival rates are higher among patients 40 years old or less as compared with patients over age 40 (95 versus 65 percent, and 75 versus 50 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. However, another study found no effect of age if survival was adjusted for baseline mortality in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Controlling for the effect of age, the prognosis of patients with inherited disease is probably similar to those with sporadic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/35,39\">",
"     35,39",
"    </a>",
"    ]. Specific germline mutations in RET predict the aggressiveness of the tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/1\">",
"     1",
"    </a>",
"    ]. As an example, patients with MEN2B (germline RET mutation codon 918) are more likely to have invasive disease, and therefore a worse prognosis, than those with either MEN2A or familial MTC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/39\">",
"     39",
"    </a>",
"    ]. In some [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/16-18\">",
"     16-18",
"    </a>",
"    ] but not other [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/19\">",
"     19",
"    </a>",
"    ] studies, tumors with an identifiable RET mutation (ie, a somatic mutation) had a more aggressive course than those without a mutation.",
"   </p>",
"   <p>",
"    Other factors that may predict a poor prognosis include cellular heterogeneity, paucity of tumor immunostaining for calcitonin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/40\">",
"     40",
"    </a>",
"    ], prominent tissue immunostaining for galectin-3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/41\">",
"     41",
"    </a>",
"    ] or immunostaining for carcinoembryonic antigen associated with scant or absent tissue staining for calcitonin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/42\">",
"     42",
"    </a>",
"    ], high preoperative serum CEA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/43\">",
"     43",
"    </a>",
"    ], a less than 10-fold increase in preoperative calcitonin levels after stimulation with pentagastrin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/44\">",
"     44",
"    </a>",
"    ], persistent hypercalcitoninemia after thyroidectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/23\">",
"     23",
"    </a>",
"    ], and an elevated procalcitonin:calcitonin ratio [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38263/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12719789\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The preoperative evaluation of medullary thyroid cancer includes measurement of serum calcitonin, carcinoembryonic antigen (CEA), calcium, and plasma fractionated metanephrines. Imaging of the neck, chest, and upper abdomen is necessary to assess for regional disease and distant metastases. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Preoperative evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link&amp;anchor=H6#H6\">",
"       \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\", section on 'Evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Some patients with apparently sporadic MTC have unsuspected germline RET mutations (the underlying defect in MEN2) and, therefore, heritable disease. We offer germline RET mutation analysis to all patients with newly diagnosed apparently sporadic MTC. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Preoperative evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link&amp;anchor=H1589190#H1589190\">",
"       \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\", section on 'Genetic screening in sporadic MTC'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with MTC, we recommend total thyroidectomy rather than lobectomy for initial therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Routine prophylactic or therapeutic dissection of the nodal tissue in the central compartment from the hyoid bone to the innominate veins and medial to the jugular veins is recommended with consideration of prophylactic lateral neck dissection if gross disease is identified in the adjacent central compartment. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Initial surgical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thyroxine (T4) therapy should be started immediately after surgery. The goal of T4 therapy is to restore and maintain euthyroidism. Suppression of serum TSH concentrations to less than normal is not indicated in patients with MTC because C cells are not TSH-responsive. Similarly, adjuvant therapy with radioiodine is not appropriate, because the tumor cells do not concentrate iodine. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Thyroxine therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with undetectable post-operative calcitonin levels, we measure serum calcitonin and CEA levels twice yearly for two years and then yearly if values are stable. We typically obtain a neck ultrasound 6 to 12 months post-operatively to establish a baseline. Serial ultrasound (US) evaluations are not required in patients with undetectable post-operative calcitonin levels. (See",
"      <a class=\"local\" href=\"#H70496114\">",
"       'Long-term monitoring for patients with undetectable post-operative serum calcitonin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with post-operative calcitonin levels that are detectable but less than 150",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      (two to six months after surgery) should have neck imaging (US with or without CT or MRI) to identify persistent loco-regional disease. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Management of residual and recurrent disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with post-operative calcitonin levels that are greater than 150",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      (two to six months after surgery) should undergo additional imaging (CT or MRI of neck, chest, and abdomen; bone scan or bone MRI in patients suspected of having skeletal metastases) to identify possible distant metastases. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Management of residual and recurrent disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiotherapy to the neck and upper mediastinum may be appropriate after primary surgery in patients with extrathyroidal disease or extensive nodal metastases who do not undergo curative dissection. Patients with progressive metastatic disease who cannot be treated by surgery or radiotherapy should be considered candidates for systemic therapy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Radiotherapy for residual disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment of advanced or residual disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/1\">",
"      American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009; 19:565.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) - Guidelines file://www.nccn.org/professionals/physician_gls/f_guidelines.asp (Accessed on July 26, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/3\">",
"      Cohen R, Campos JM, Sala&uuml;n C, et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 2000; 85:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/4\">",
"      Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 1984; 63:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/5\">",
"      Scollo C, Baudin E, Travagli JP, et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 2003; 88:2070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/6\">",
"      Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg 2008; 95:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/7\">",
"      Kebebew E, Ituarte PH, Siperstein AE, et al. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000; 88:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/8\">",
"      Duh QY, Sancho JJ, Greenspan FS, et al. Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy. Arch Surg 1989; 124:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/9\">",
"      Fleming JB, Lee JE, Bouvet M, et al. Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 1999; 230:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/10\">",
"      Witt RL. What is the treatment of the lateral neck in clinically localized sporadic medullary thyroid cancer? Laryngoscope 2010; 120:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/11\">",
"      Saad MF, Guido JJ, Samaan NA. Radioactive iodine in the treatment of medullary carcinoma of the thyroid. J Clin Endocrinol Metab 1983; 57:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/12\">",
"      Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'&eacute;tude des tumeurs &agrave; calcitonine. Clin Endocrinol (Oxf) 1998; 48:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/13\">",
"      Stepanas AV, Samaan NA, Hill CS Jr, Hickey RC. Medullary thyroid carcinoma: importance of serial serum calcitonin measurement. Cancer 1979; 43:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/14\">",
"      Barbet J, Campion L, Kraeber-Bod&eacute;r&eacute; F, et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 2005; 90:6077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/15\">",
"      Laure Giraudet A, Al Ghulzan A, Aup&eacute;rin A, et al. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol 2008; 158:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/16\">",
"      Zedenius J, Larsson C, Bergholm U, et al. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. J Clin Endocrinol Metab 1995; 80:3088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/17\">",
"      Romei C, Elisei R, Pinchera A, et al. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab 1996; 81:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/18\">",
"      Elisei R, Cosci B, Romei C, et al. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 2008; 93:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/19\">",
"      Marsh DJ, Learoyd DL, Andrew SD, et al. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf) 1996; 44:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/20\">",
"      Jackson CE, Talpos GB, Kambouris A, et al. The clinical course after definitive operation for medullary thyroid carcinoma. Surgery 1983; 94:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/21\">",
"      Wells SA Jr, Dilley WG, Farndon JA, et al. Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med 1985; 145:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/22\">",
"      Scopsi L, Sampietro G, Boracchi P, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients. Cancer 1996; 78:2173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/23\">",
"      Dottorini ME, Assi A, Sironi M, et al. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 1996; 77:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/24\">",
"      Pelizzo MR, Boschin IM, Bernante P, et al. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients. Eur J Surg Oncol 2007; 33:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/25\">",
"      Ong SC, Sch&ouml;der H, Patel SG, et al. Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 2007; 48:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/26\">",
"      Bern&aacute; L, Cabezas R, Mora J, et al. 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. J Endocrinol 1995; 144:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/27\">",
"      Udelsman R, Ball D, Baylin SB, et al. Preoperative localization of occult medullary carcinoma of the thyroid gland with single-photon emission tomography dimercaptosuccinic acid. Surgery 1993; 114:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/28\">",
"      Gotthardt M, B&eacute;h&eacute; MP, Beuter D, et al. Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2006; 33:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/29\">",
"      Abdelmoumene N, Schlumberger M, Gardet P, et al. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer 1994; 69:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/30\">",
"      van Heerden JA, Grant CS, Gharib H, et al. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 1990; 212:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/31\">",
"      Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986; 99:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/32\">",
"      Moley JF, Wells SA, Dilley WG, Tisell LE. Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 1993; 114:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/33\">",
"      Fialkowski E, DeBenedetti M, Moley J. Long-term outcome of reoperations for medullary thyroid carcinoma. World J Surg 2008; 32:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/34\">",
"      van Veelen W, de Groot JW, Acton DS, et al. Medullary thyroid carcinoma and biomarkers: past, present and future. J Intern Med 2009; 266:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/35\">",
"      Samaan NA, Schultz PN, Hickey RC. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 1988; 67:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/36\">",
"      Brierley J, Tsang R, Simpson WJ, et al. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 1996; 6:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/37\">",
"      Fromigu&eacute; J, De Baere T, Baudin E, et al. Chemoembolization for liver metastases from medullary thyroid carcinoma. J Clin Endocrinol Metab 2006; 91:2496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/38\">",
"      de Groot JW, Plukker JT, Wolffenbuttel BH, et al. Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clin Endocrinol (Oxf) 2006; 65:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/39\">",
"      O'Riordain DS, O'Brien T, Weaver AL, et al. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery 1994; 116:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/40\">",
"      Lippman SM, Mendelsohn G, Trump DL, et al. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab 1982; 54:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/41\">",
"      Faggiano A, Talbot M, Lacroix L, et al. Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia. Clin Endocrinol (Oxf) 2002; 57:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/42\">",
"      Mendelsohn G, Wells SA Jr, Baylin SB. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease. Cancer 1984; 54:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/43\">",
"      Machens A, Ukkat J, Hauptmann S, Dralle H. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Arch Surg 2007; 142:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/44\">",
"      Machens A, Hauptmann S, Dralle H. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endocrinol Metab 2008; 93:2234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38263/abstract/45\">",
"      Walter MA, Meier C, Radimerski T, et al. Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer 2010; 116:31.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2190 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.18-587BC34546-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38263=[""].join("\n");
var outline_f37_23_38263=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12719789\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREOPERATIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INITIAL SURGICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      POSTOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Thyroxine therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Serum calcitonin and CEA measurement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12650995\">",
"      Assessment for sporadic RET mutation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H70496114\">",
"      Long-term monitoring for patients with undetectable post-operative serum calcitonin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MANAGEMENT OF RESIDUAL AND RECURRENT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9088928\">",
"      Persistent hypercalcitoninemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Surgery for residual disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Radiotherapy for residual disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TRANSARTERIAL CHEMOEMBOLIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT OF ADVANCED OR RESIDUAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2736614\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12719789\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8872?source=related_link\">",
"      Approach to therapy in multiple endocrine neoplasia type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/47/23288?source=related_link\">",
"      Chemotherapy and immunotherapy for medullary thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=related_link\">",
"      Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=related_link\">",
"      Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=related_link\">",
"      Surgical treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_23_38264="Hamman Rich Low";
var content_f37_23_38264=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F63702&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F63702&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute interstitial pneumonia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 284px; height: 186px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph shows dramatic interstitial thickening in a patient with acute interstitial pneumonia (Hamman-Rich disease). The prominent air spaces represent alveolar ducts while the intervening lung shows collapsed alveolar septa distorted by proliferating fibroblasts and myofibroblasts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey L Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal lung",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph of normal lung tissue shows open alveoli with thin, capillary- containing interstitial spaces. An artery (A) is identifiable by its thick, muscular wall; the accompanying bronchus (B) contains mucoid material and is lined by columnar respiratory epithelial cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven E Weinberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38264=[""].join("\n");
var outline_f37_23_38264=null;
var title_f37_23_38265="Reirradiation for locally recurrent head and neck cancer";
var content_f37_23_38265=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Reirradiation for locally recurrent head and neck cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38265/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38265/contributors\">",
"     Michael T Milano, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38265/contributors\">",
"     Joseph K Salama, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38265/contributors\">",
"     Daniel J Haraf, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38265/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38265/contributors\">",
"     David M Brizel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/23/38265/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/23/38265/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/23/38265/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite advances in the treatment of head and neck cancer, 15 to 50 percent of patients will develop recurrent disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. Survivors also are at risk to develop second primary tumors, the incidence of which is estimated at 8 to 22 percent with about a third occurring in the head and neck. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/58/15270?source=see_link\">",
"     \"Second primary malignancies in patients with head and neck cancers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Therapeutic options are limited for patients who present with locally recurrent disease or a second primary tumor in a previously irradiated field. Surgical salvage with a curative-intent resection is the preferred option for those with limited-volume disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. Reirradiation is an alternative for patients who are not candidates for surgical salvage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reirradiation with or without the addition of chemotherapy may hold promise for long-term survival for appropriately selected patients. Indications for reirradiation may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who undergo surgical salvage but are found to have high-risk features.",
"     </li>",
"     <li>",
"      Patients who are medically suitable for curative-intent interventions but are not amenable to curative-intent resection.",
"     </li>",
"     <li>",
"      Patients who are not candidates for curative-intent interventions, but may benefit from palliative treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    General principles of treatment for locally recurrent and second primary head and neck cancer are discussed separately. Recurrence of nasopharynx cancer has a markedly better prognosis than other head and neck sites, and its management is also discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9559?source=see_link\">",
"       \"Treatment of locally recurrent head and neck cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/58/15270?source=see_link\">",
"       \"Second primary malignancies in patients with head and neck cancers\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/3/8250?source=see_link\">",
"       \"Treatment of early and locoregionally advanced nasopharyngeal carcinoma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H798962322\">",
"    <span class=\"h2\">",
"     Patient selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient selection is critical since reirradiation, with or without chemotherapy, is associated with considerable acute and late toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/9,11\">",
"     9,11",
"    </a>",
"    ]. Patient selection is based on tumor characteristics, as well as an assessment of the patients' prognosis and their ability and willingness to tolerate the anticipated toxicity of these regimens. Patients who recur within the high dose radiation area less than six months after the first course of radiation generally have radiation resistant disease and are not usually considered candidates for a second course of radiation.",
"   </p>",
"   <p>",
"    Tissues of the head and neck such as skin, nerves, blood vessels, and spinal cord normally receive maximally tolerated radiation doses during the initial course of radiation therapy (RT). Reirradiation, by exposing tissue to further radiation, incurs a risk of severe long-term complications such as carotid artery stenosis or rupture, osteoradionecrosis, pharyngocutaneous fistulas, non-healing skin ulcers, and spinal cord damage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22554?source=see_link\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30378?source=see_link\">",
"     \"Management of late complications of head and neck cancer and its treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Radioresistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of a tumor recurrence in a previously irradiated field suggests the existence of a radioresistant clone that would limit the therapeutic effect of reirradiation. The initial disease-free interval plays an important role in the decision of whether or not to reirradiate. Patients with tumor recurrence within six months after the first course of radiation are generally thought to have radiation-resistant disease and therefore to be unlikely to benefit from a second course of radiation.",
"   </p>",
"   <p>",
"    The problem of radioresistance may be particularly relevant to patients who develop local recurrence after initial treatment with concurrent chemoradiotherapy. Strategies to overcome radioresistance include the addition of radiation sensitizers, such as chemotherapy and targeted agents, and dose escalation or intensification, with techniques such as hyperfractionation, accelerated fractionation, conformal RT, and brachytherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/12-16\">",
"     12-16",
"    </a>",
"    ]. Ideally, a systemic agent different from that originally used for concurrent therapy should be employed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/62/28649?source=see_link\">",
"     \"Methods to overcome radiation resistance in head and neck cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/7/17525?source=see_link\">",
"     \"General principles of radiation therapy for head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Treatment volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough analysis of the initial treatment volumes and dose distributions relative to the location of the locoregional recurrence should be made when reirradiation is considered. Determination of the dose received at the site of recurrence may demonstrate geographic tumor miss and is necessary for treatment planning, since a geographic or marginal miss may not represent the same radioresistant disease as a true in-field recurrence even with a disease-free interval of less than a year.",
"   </p>",
"   <p>",
"    Reirradiation treatment volumes are typically limited to a 1 to 2 cm margin around gross tumor or the surgical site, with even smaller margins when tumors are near critical structures, such as the spinal cord, optic nerve, or optic chiasm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/13\">",
"     13",
"    </a>",
"    ]. This approach was validated in a retrospective review of 66 reirradiated patients, which demonstrated that 96 percent of locoregional recurrences following reirradiation occurred within the gross tumor volume and only 4 percent occurred in untreated regional sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/17\">",
"     17",
"    </a>",
"    ]. The lifetime spinal cord dose is usually limited to 50 gray (Gy) with the reirradiation dose to the spinal cord restricted to 10 percent of the prescribed reirradiation dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/13,18\">",
"     13,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doses &ge;50 Gy to the tumor are necessary to yield substantial response rates and delay disease recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/19\">",
"     19",
"    </a>",
"    ]. Many investigators and cooperative groups use 60 Gy as a target reirradiation dose, delivered through various reirradiation protocols [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/12,20\">",
"     12,20",
"    </a>",
"    ]. Some large analyses demonstrate that patients treated to higher radiation dose have improved outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/21\">",
"     21",
"    </a>",
"    ]. Therefore, we use an alternating-week schedule of 1.5 Gy fractions twice daily or 2 Gy once daily for five days followed by a nine-day break. However, there is no consensus regarding total dose or use of any particular dose fractionation scheme. For patients with gross disease, we typically prescribe 70 to 75 Gy, and for those treated following gross total resection, we prescribe 60 to 66 Gy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Modality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three-dimensional conformal planning, advanced delivery techniques such as intensity modulated radiation therapy (IMRT), brachytherapy, intraoperative radiotherapy, stereotactic radiosurgery, and stereotactic body radiotherapy have been used to deliver high doses to tumors while minimizing the radiation dose to surrounding normal structures. Most of the data describing long-term outcomes of patients treated with reirradiation and chemotherapy and reirradiation were treated with two-dimensional and three-dimensional radiotherapy.",
"   </p>",
"   <p>",
"    Contemporary reports have demonstrated promising outcomes with the use of more conformal radiotherapy techniques such as IMRT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/22\">",
"     22",
"    </a>",
"    ]. Additionally, the use of fewer high doses of radiation therapy in selected patients (termed stereotactic body radiotherapy [SBRT]) has been investigated alone or in combination with chemotherapy and has also been associated with promising outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/23\">",
"     23",
"    </a>",
"    ]. Further investigations are ongoing to further investigate the integration of newer radiation techniques for the use of reirradiation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/7/17525?source=see_link\">",
"     \"General principles of radiation therapy for head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Elective neck treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the case of local tumor recurrence, the need for prophylactic irradiation to the neck is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/12\">",
"     12",
"    </a>",
"    ]. Some treat if the elective nodal areas are outside of the high dose area of previous irradiation or were not irradiated initially; however, others consider this to significantly increase the risk of side effects. However, we do not routinely treat elective nodal regions since the primary pattern of recurrence is in the reirradiated site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE REIRRADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The addition of postoperative reirradiation to surgical salvage may improve upon the results using surgery alone. Retrospective reviews and phase",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    trials established the feasibility of postoperative reirradiation and suggested promising outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. The Groupe d'Etude des Tumours Tete et Cou (GETTEC) in conjunction with Groupe d'Oncologie Radiotherapie Tete et Cou (GORTEC) conducted a prospective, randomized trial to confirm these results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/26\">",
"     26",
"    </a>",
"    ]. After a macroscopic complete resection, 130 patients were randomized to reirradiation (60 Gy in 12 weeks) in combination with chemotherapy (5-fluorouracil plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/16/16648?source=see_link\">",
"     hydroxyurea",
"    </a>",
"    ) or no postoperative therapy. Postoperative reirradiation was associated with an improvement in progression-free survival (hazard ratio 1.6, 95% CI 1.1-2.4), but not overall survival.",
"   </p>",
"   <p>",
"    Subsequently, many have focused attention on those patients at highest risk of second failure after surgical salvage: those who have undergone macroscopic complete resections but were found to have high risk pathologic features, including positive margins, perineural invasion, lymphovascular invasion, or extranodal extension. In non-randomized trials, a three-year survival of 48 percent with postoperative reirradiation alone and a four-year overall survival of 43 percent with postoperative reirradiation with concurrent chemotherapy in these high-risk patients have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients without high risk features are generally not treated with postoperative reirradiation. However, we and others recommend the routine use of postoperative reirradiation for surgically resected patients with high-risk pathologic features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/12,13,29\">",
"     12,13,29",
"    </a>",
"    ]. We suggest the use of the same concurrent chemotherapy protocols that are used for unresectable recurrences as discussed in the next section.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     REIRRADIATION FOR UNRESECTABLE RECURRENCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although retrospective reviews and phase",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    studies have demonstrated that reirradiation with or without concurrent chemotherapy is feasible and that some patients may achieve long-term survival with reirradiation, it is not clear that reirradiation, with its accompanying toxicity, is superior to chemotherapy alone.",
"   </p>",
"   <p>",
"    For appropriately selected patients, we suggest reirradiation with concurrent chemotherapy over chemotherapy or reirradiation alone. The data supporting this approach is derived from small, nonrandomized studies. Randomized trials designed to address this question were terminated because of poor accrual [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/10\">",
"     10",
"    </a>",
"    ]. Differences in patient populations due to selection bias influence outcomes and toxicity rates and limit comparisons between studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Surgical debulking prior to reirradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although surgical salvage is considered the standard of care for patients with resectable disease, the role of debulking surgery is less clear. Debulking surgery can theoretically provide immediate palliation of symptoms, remove radioresistant tumor, and allow for a reduced radiation dose",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    field size. Nevertheless, surgery may be disfiguring and can delay the start of reirradiation. Furthermore, some patients who undergo debulking surgery with a plan for subsequent chemotherapy and reirradiation never receive adjuvant therapy due to surgical complications.",
"   </p>",
"   <p>",
"    Retrospective data suggest that even in patients who have unresectable recurrences, surgical debulking prior to reirradiation increases the disease control",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/19,24,30\">",
"     19,24,30",
"    </a>",
"    ]. Although the improved outcome in these studies may have been attributable to a reduction in the tumor burden, it is also likely that selection bias was present. A prospective phase II study consisted of patients with recurrent or second primary head and neck cancer who were treated with two cycles of chemotherapy followed by local therapy (either surgery followed by chemotherapy and reirradiation or chemotherapy and reirradiation alone). Prior to the initial chemotherapy, surgeons declared if patients were surgical candidates. In the final analysis of this study, there was no difference in survival between those who underwent surgery and those who did not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical debulking can be offered to patients when it will result in an adequate enough resection to allow either sparing of normal tissues",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lower dose of prescribed radiation. Some patients may also achieve effective palliation of symptoms from surgical debulking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Reirradiation alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending upon the population examined, reasonable survival rates have been reported with primary reirradiation without chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/32-43\">",
"     32-43",
"    </a>",
"    ]. More commonly, however, chemotherapy is given concurrently to overcome radioresistance and improve outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     External beam RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Survival rates of 13 to 22 percent at three years has been reported with external beam RT alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/33,43\">",
"     33,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Emerging data support the safety and feasibility of conformal delivery techniques, such as intensity modulated radiation therapy, for the treatment of recurrent head and neck cancer with evidence that improved local control can be achieved with potentially less treatment-related toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/22,30,44\">",
"     22,30,44",
"    </a>",
"    ]. In one series, patients who underwent intensity modulated radiation therapy experienced improved two-year locoregional progression-free survival compared to those treated with conventional RT, 52 versus 20 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/44\">",
"     44",
"    </a>",
"    ]. Stereotactic body radiotherapy, which uses anatomic references (ie, skull or spine), surgically placed fiducials, external markers,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a rigid stereotactic frame to more accurately target radiation treatment, is emerging as an option for reirradiation of head and neck cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/45\">",
"     45",
"    </a>",
"    ]. Case series have reported good local control and toxicity comparable to conformal techniques as described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Brachytherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interstitial brachytherapy alone or in combination with external beam RT has yielded five-year locoregional control rates as high as 50 to 70 percent and five-year overall survival of 11 to 30 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/37,39,40,46\">",
"     37,39,40,46",
"    </a>",
"    ]. Sites amenable to this approach include the oral cavity and oropharynx.",
"   </p>",
"   <p>",
"    Brachytherapy is a reasonable treatment option for patients with recurrent disease at centers with appropriate expertise. As an example, one center has used interstitial brachytherapy for recurrent head and neck cancer since the mid 1970's, initially with low dose rate brachytherapy and then transitioning to high dose rate brachytherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/40\">",
"     40",
"    </a>",
"    ]. In the most recent report of their experience with high dose rate brachytherapy delivered at doses of 18 to 48 Gy in 3 to 4 Gy, twice daily fractions, the two-year disease-specific and overall survival rates were 45 and 37 percent, respectively. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/7/17525?source=see_link\">",
"     \"General principles of radiation therapy for head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Intraoperative RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative RT (with electrons or high-dose-rate brachytherapy) combined with debulking surgery allows visualization of the target and avoidance of uninvolved structures. Two-year local control rates and overall survival of 60 and 55 percent have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/41,47\">",
"     41,47",
"    </a>",
"    ]. While local control rates with intraoperative RT are acceptable with completely resected disease, high local failure rates may preclude its use for gross residual disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Reirradiation with concurrent chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several institutions have developed protocols for reirradiation with concurrent chemotherapy and reported promising results from single-institution phase",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    trials. These results have been repeated in the multi-institutional cooperative group setting, and in one study, the benefit of reirradiation with concurrent chemotherapy over observation was demonstrated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/26,48,49\">",
"     26,48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Until additional data are published, we favor reirradiation with concurrent chemotherapy over either chemotherapy alone or RT alone. Although there is no standard concurrent chemotherapy regimen for use with reirradiation, patients should be treated with established regimens, which are discussed below, or encouraged to participate in clinical trials. The chemotherapy regimen should avoid drugs to which the patient was previously exposed.",
"   </p>",
"   <p>",
"    Patient selection is critical as these regimens are associated with considerable toxicity. Patient selection is based upon tumor characteristics, as well as an assessment of the patients' prognosis and their ability and willingness to tolerate the anticipated toxicity of these regimens. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Toxicity'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H29\">",
"     'Prognostic factors'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     FHX/FHX2 regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the best studied combinations is concomitant 5-fluorouracil (5-FU) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/16/16648?source=see_link\">",
"     hydroxyurea",
"    </a>",
"    with reirradiation (FHX) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/19,20,26,48\">",
"     19,20,26,48",
"    </a>",
"    ]. Investigators at the University of Chicago have reported on 45 patients enrolled in four prospective phase I-II trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/50\">",
"     50",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     Cisplatin",
"    </a>",
"    was added to the chemotherapy regimen in three of the four trials. Five-year locoregional control, PFS, and overall survival were 14, 15, and 20 percent, respectively.",
"   </p>",
"   <p>",
"    For the original FHX protocol, RT was delivered on alternating weeks (five-day treatment cycle followed by a nine day break). The regimen was modified in subsequent studies to twice daily,",
"    <span class=\"nowrap\">",
"     week-on/week-off",
"    </span>",
"    RT (FHX2).",
"   </p>",
"   <p>",
"    RTOG 9610, which included 81 patients, tested FHX2, but with a lower 5-FU dose, in the cooperative group setting. The two-year and five-year survival rates were 15 and 4 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/48,51\">",
"     48,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     FHX2 plus paclitaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;Results from the addition of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    to FHX2 (TFHX2) were reported at the 2003 American Society for Radiation Oncology (ASTRO) meeting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/52\">",
"     52",
"    </a>",
"    ]. Four-year locoregional control rates and survival were 54 and 22, percent respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     FGX2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Promising results but significant acute toxicity have been reported with concurrent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    , and 5-FU in conjunction with twice-daily radiotherapy delivered on alternating weeks (TFGX2) with five-year locoregional control and overall survival of 55 and 35 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a pooled analysis of 115 patients treated with",
"    <span class=\"nowrap\">",
"     FHX/FHX2,",
"    </span>",
"    FHX plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    , TFHX2, and TFGX2 regimens at the University of Chicago, the three-year locoregional control rates, PFS, and overall survival were 51, 33, and 22 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Platinum combinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Promising single institution results with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    concurrent with hyperfractionated RT have been replicated in a cooperative group phase II trial, RTOG 9911 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/49,53\">",
"     49,53",
"    </a>",
"    ]. Hematopoietic growth factor, G-CSF, was added to the protocol to reduce the acute toxicity and treatment delays experienced during the initial studies. With 99 patients treated and 74 percent completing therapy, two-year PFS and overall survival rates were 16 and 26 percent, respectively. These survival rates are superior to the results from RTOG 9610 and exceed those generally seen with chemotherapy alone. However, they do come at the cost of apparent increased toxicity and caution is warranted in comparing nonrandomized trials.",
"   </p>",
"   <p>",
"    This regimen of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    was selected as the concurrent chemotherapy for the reirradiation arm in RTOG 0421; however, this trial has closed due to poor accrual [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other promising platinum regimens include",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"      carboplatin",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"      paclitaxel",
"     </a>",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/55\">",
"     55",
"    </a>",
"    ],",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/59/41913?source=see_link\">",
"      docetaxel",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"      cisplatin",
"     </a>",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/56\">",
"     56",
"    </a>",
"    ],",
"    <span class=\"nowrap\">",
"     cisplatin/5-FU",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/57\">",
"     57",
"    </a>",
"    ], and",
"    <span class=\"nowrap\">",
"     carboplatin/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"      pemetrexed",
"     </a>",
"     ,",
"    </span>",
"    which have been used in combination with induction chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/58\">",
"     58",
"    </a>",
"    ]. Cisplatin alone, concurrent with reirradiation, is also used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Induction chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Induction chemotherapy followed by surgery and reirradiation has been investigated based upon results in the first-line therapy of advanced head and neck cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/15/29946?source=see_link&amp;anchor=H281026593#H281026593\">",
"     \"Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy\", section on 'Induction chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Induction with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    , followed by resection, in patients amenable to surgery, and then reirradiation with concurrent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    and pemetrexed yielded a one-year survival rate of 42 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/58\">",
"     58",
"    </a>",
"    ]. Poor response to induction chemotherapy predicted worse survival, a finding that may be used in subsequent studies to select patients for reirradiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Novel/targeted agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;New agents, alone or in combination with cytotoxic chemotherapy, are being added to reirradiation as a means of overcoming radioresistance.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/63/11257?source=see_link\">",
"     Bortezomib",
"    </a>",
"    has been studied in conjunction with reirradiation; however, the regimen was not feasible due to toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon existing evidence that antiangiogenesis agents may overcome radioresistance, these agents are being tested in the setting of recurrence and reirradiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/61\">",
"     61",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/20/2377?source=see_link\">",
"     Bevacizumab",
"    </a>",
"    , added to FHX, has been tested in a phase I study and a phase II trial is ongoing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/62\">",
"     62",
"    </a>",
"    ]. A phase I study has demonstrated the feasibility of an intra-tumoral injection of TNFerade (a replication defective adenoviral vector that carries a human tumor necrosis factor (TNF) gene linked to the radiation inducible promoter, early growth response protein (EGR-1)) in conjunction with FHX2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Isolated neck recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical salvage of an isolated neck recurrence is a standard curative-intent approach, and specific surgical issues that pertain to the irradiated neck are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9559?source=see_link\">",
"     \"Treatment of locally recurrent head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Interstitial brachytherapy and intraoperative radiotherapy are ideal for treatment of an isolated neck recurrence since the radiation dose can be selectively delivered to the neck. However, scant data exist. In one series of 22 patients treated with salvage neck dissection and low dose rate brachytherapy, the two-year regional control and overall survival rates were 67 and 57 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/64\">",
"     64",
"    </a>",
"    ]. Others, after appreciating that reirradiation of the neck with brachytherapy resulted in necrosis and fibrosis in 42 percent of patients, modified the technique to include skin resurfacing with a myocutaneous graft. Subsequently, this complication rate was lowered to 11 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PALLIATIVE REIRRADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are limited, palliative irradiation is an option for patients whose tumor is significantly impacting quality of life and who are not candidates for an aggressive course of reirradiation. In general, tumor shrinkage with palliative reirradiation is expected to be greater than the response to chemotherapy. Lower doses and larger fraction sizes are delivered to patients receiving palliative reirradiation. The lower dose should result in a lower risk of acute toxicity, and the increased risk of late complications with larger fraction sizes is generally not relevant.",
"   </p>",
"   <p>",
"    Patients with multifocal locoregional recurrences, metastatic disease, and short interval between initial treatment and recurrence have such a limited survival that the likelihood of severe complications may outweigh any palliative benefit from reirradiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/33,66\">",
"     33,66",
"    </a>",
"    ]. Systemic therapy for metastatic and recurrent head and neck cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/25/40345?source=see_link\">",
"     \"Treatment of metastatic and recurrent head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     TOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reirradiation is a treatment option for some patients, but toxicity can be an important consideration. Acute and long term complications, including treatment-related fatalities from bleeding, tissue necrosis, and infection, are substantial. Appropriate patient selection and the availability of adequate supportive care are important. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22554?source=see_link\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30378?source=see_link\">",
"     \"Management of late complications of head and neck cancer and its treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Reirradiation alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even with reirradiation alone, without concurrent chemotherapy, toxicity is high. A series of 41 patients, 78 percent treated with intensity modulated radiation therapy, reported radiation-related toxicity and disease-related problems occurring in 81 percent of patients with grade 3 or 4 toxicity in 68 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/33\">",
"     33",
"    </a>",
"    ]. Acute complications in this setting are mainly mucositis and pain.",
"   </p>",
"   <p>",
"    Long-term toxicity from reirradiation has been limited by reductions in the size of the target volume with conformal delivery techniques and by adopting split-course schedules with smaller fraction sizes. With these modifications, the incidence of radiation necrosis is generally less than 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/29,49\">",
"     29,49",
"    </a>",
"    ]. Severe late complications, each with an incidence as high as 5 percent, include mucosal",
"    <span class=\"nowrap\">",
"     ulceration/necrosis,",
"    </span>",
"    neck fibrosis, trismus, orocutaneous fistula, carotid blow out, hemorrhage,",
"    <span class=\"nowrap\">",
"     chondronecrosis/osteoradionecrosis,",
"    </span>",
"    feeding tube dependency, and death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Reirradiation with chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The addition of chemotherapy to RT has added to the toxicity in most reports. Evidence suggests that acute toxicity with reirradiation and concurrent chemotherapy is similar to the toxicity associated with an initial course of concurrent chemoradiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/26,48,49,51\">",
"     26,48,49,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following two trials illustrate the scope and high rates of toxicity with reirradiation and concurrent chemotherapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      RTOG 9610: Acute toxicity, occurring within 90 days of the start of treatment, resulted in death in 6 of 79 treated patients (8 percent), two due to hemorrhage and four due to neutropenia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/48\">",
"       48",
"      </a>",
"      ]. Grade 3 to 5 overall, nonhematologic, and hematologic acute toxicity occurred in 63, 49, and 37 percent of patients, respectively.",
"     </li>",
"     <li>",
"      RTOG 9911: The total treatment-related fatality rate was 11 percent, with 5 percent occurring in the acute period [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/49\">",
"       49",
"      </a>",
"      ]. Cause of death included neutropenic sepsis, dehydration and shock, pneumonitis, and stroke. Grade 3 to 5 overall, nonhematologic, and hematologic acute toxicity occurred in 78, 77, and 45 percent of patients, respectively. Of these, grade 3 to 5 neutropenia occurred in 24 percent,",
"      <span class=\"nowrap\">",
"       infection/neutropenic",
"      </span>",
"      fever in 15 percent, mucositis in 14 percent, and GI toxicity in 48 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Differentiating the toxicity of reirradiation from that of previous treatment can be difficult. In RTOG 9610 the cumulative incidence of grade 3 or greater toxicity in patients surviving more than one year was 12 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/48,51\">",
"     48,51",
"    </a>",
"    ]. In RTOG 9911, an estimated 85 and 32 percent experienced overall and nonhematologic grade 3 to 5 toxicity over the first two years of follow-up. There were three late fatalities in RTOG 9911, two due to carotid hemorrhages and one from oral-cutaneous fistula and soft tissue necrosis. Late toxicities reported in these trials and others include cervical fibrosis (31 to 48 percent), osteoradionecrosis (5 to 16 percent), trismus (9 to 24 percent), and carotid hemorrhage (2 to 5 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/13\">",
"     13",
"    </a>",
"    ]. Although long-term spinal cord and brainstem toxicity has been rare, this may be due to selection of patients with tumors not in close proximity to the spinal cord [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/19,48,49,51\">",
"     19,48,49,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Radioprotectants",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/42/678?source=see_link\">",
"     Amifostine",
"    </a>",
"    , which reduces the incidence of acute and long term xerostomia, was added in a pilot study of reirradiation with concurrent",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"      cisplatin",
"     </a>",
"     /5-FU",
"    </span>",
"    chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/57\">",
"     57",
"    </a>",
"    ]. Although the administration of intravenous amifostine was feasible with 13 of 16 patients receiving at least 90 percent of the amifostine dose, little can be concluded about its efficacy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22554?source=see_link&amp;anchor=H722454217#H722454217\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\", section on 'Amifostine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36084?source=see_link\">",
"     Palifermin",
"    </a>",
"    , a recombinant human keratinocyte growth factor, may also be considered. In two phase III trials, palifermin reduced the incidence and severity of mucositis during definitive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/67\">",
"     67",
"    </a>",
"    ] and postoperative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/68\">",
"     68",
"    </a>",
"    ] chemoradiation of newly diagnosed head and neck cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22554?source=see_link&amp;anchor=H722454631#H722454631\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\", section on 'Palifermin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Carotid artery injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carotid artery hemorrhage and rupture is a particularly dreaded complication of reirradiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/29\">",
"     29",
"    </a>",
"    ]. In a literature review of 27 series that included 1554 patients, the rate of carotid blowout was 2.6 percent, and appeared to be higher in patients treated with accelerated fractionation regimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/69\">",
"     69",
"    </a>",
"    ]. Patients with long-term tracheostomies, active infections, pharyngocutaneous fistulas, poor wound healing, prior neck dissection, and tumor adherent to the carotid fascia are at particular risk for this complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30378?source=see_link&amp;anchor=H3822529#H3822529\">",
"     \"Management of late complications of head and neck cancer and its treatment\", section on 'Carotid artery injury'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stabilization of the carotid, by means of a surgical flap reconstruction or an endovascular stent, prior to reirradiation in patients at risk has been proposed but is untested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/8,71\">",
"     8,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     PROGNOSTIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several factors have been identified as prognostic of both locoregional control and survival for patients undergoing reirradiation for recurrent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    second primary tumors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Second primary tumors fare better than recurrent tumors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/32,51\">",
"       32,51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Surgical debulking of the recurrent tumor is associated with improved outcomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/19,21,24,26,44\">",
"       19,21,24,26,44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Extensive recurrent disease is associated with worse outcomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/11,33,66\">",
"       11,33,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A longer time interval to recurrence affords a better prognosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/11,13,21,48,72\">",
"       11,13,21,48,72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Laryngeal and nasopharyngeal tumors have a more favorable prognosis as compared to other sites [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/42,44,73,74\">",
"       42,44,73,74",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Recurrences in the neck fare poorly as compared to primary site recurrences [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/59,75\">",
"       59,75",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Higher doses of RT yield better outcome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/11,19,21,24,44,57\">",
"       11,19,21,24,44,57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Multi-agent chemotherapy has been associated not only with improved survival but also decreased distant metastases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Medical comorbidities and",
"      <span class=\"nowrap\">",
"       laryngeal/pharyngeal",
"      </span>",
"      organ dysfunction have a markedly negative impact on survival [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/76\">",
"       76",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prior treatment with concomitant chemotherapy and radiation has a worse survival [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/23/38265/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients presenting with recurrent head and neck cancer in a previously irradiated field present a therapeutic challenge. Salvage surgery, if feasible, represents the preferred treatment option. Reirradiation with or without chemotherapy has become an accepted alternative to chemotherapy or supportive care and may offer long-term survival for selected patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because of the toxicity associated with reirradiation for recurrent head and neck cancer or a second primary tumor, patient selection is critical. Factors to be considered include the dose of prior radiation and the radiation fields, time since prior treatment, the extent and location of recurrent tumor, and overall patient condition and comorbidities. (See",
"      <a class=\"local\" href=\"#H798962322\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with high-risk pathologic features after surgical resection of a recurrence or second primary, we suggest postoperative reirradiation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Postoperative Reirradiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients without high-risk features after surgical resection of a recurrence or second primary, we do not suggest postoperative reirradiation (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Postoperative Reirradiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For selected patients with unresectable locally recurrent head and neck cancer without distant metastases, we suggest reirradiation with concurrent chemotherapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Reirradiation with concurrent chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest complete surgical resection prior to reirradiation, if feasible (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Surgical debulking prior to reirradiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no standard concurrent chemotherapy regimen. Patients should be treated with established regimens (eg, the FHX regimen or a",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"      -platinum combination) or encouraged to participate in clinical trials. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Reirradiation with concurrent chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For some patients who are not candidates for curative-intent treatment but who have symptomatic local disease or who are likely to experience symptoms from local progression, palliative reirradiation may provide symptom relief. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Palliative reirradiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Toxicity from reirradiation is considerable. Treatment-related fatality approaches 10 percent. The incidence of acute and late grade 3 to 5 hematologic and nonhematologic toxicities ranges from 15 to 50 percent. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Toxicity'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22554?source=see_link\">",
"       \"Management and prevention of complications of head and neck cancer during initial treatment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30378?source=see_link\">",
"       \"Management of late complications of head and neck cancer and its treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/1\">",
"      Bourhis J, Le Ma&icirc;tre A, Baujat B, et al. Individual patients' data meta-analyses in head and neck cancer. Curr Opin Oncol 2007; 19:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/2\">",
"      Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004; 15:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/3\">",
"      Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350:1945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/4\">",
"      Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350:1937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/5\">",
"      Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349:2091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/6\">",
"      Hall SF, Groome PA, Irish J, O'Sullivan B. The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 2008; 118:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/7\">",
"      Kao J, Garofalo MC, Milano MT, et al. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 2003; 29:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/8\">",
"      Chmura SJ, Milano MT, Haraf DJ. Reirradiation of recurrent head and neck cancers with curative intent. Semin Oncol 2004; 31:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/9\">",
"      McDonald MW, Lawson J, Garg MK, et al. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys 2011; 80:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/10\">",
"      Patel PR, Salama JK. Reirradiation for recurrent head and neck cancer. Expert Rev Anticancer Ther 2012; 12:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/11\">",
"      Chen AM, Phillips TL, Lee NY. Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much? Int J Radiat Oncol Biol Phys 2011; 81:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/12\">",
"      Langendijk JA, Bourhis J. Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol 2007; 19:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/13\">",
"      Salama JK, Vokes EE. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. Semin Oncol 2008; 35:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/14\">",
"      Seiwert TY, Salama JK, Vokes EE. The concurrent chemoradiation paradigm--general principles. Nat Clin Pract Oncol 2007; 4:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/15\">",
"      Bentzen SM, Harari PM, Bernier J. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions. Nat Clin Pract Oncol 2007; 4:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/16\">",
"      Wilson GD, Bentzen SM, Harari PM. Biologic basis for combining drugs with radiation. Semin Radiat Oncol 2006; 16:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/17\">",
"      Popovtzer A, Gluck I, Chepeha DB, et al. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys 2009; 74:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/18\">",
"      Nieder C, Grosu AL, Andratschke NH, Molls M. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. Int J Radiat Oncol Biol Phys 2005; 61:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/19\">",
"      Salama JK, Vokes EE, Chmura SJ, et al. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2006; 64:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/20\">",
"      Spencer SA, Wheeler RH, Peters GE, et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol 1999; 22:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/21\">",
"      Choe KS, Haraf DJ, Solanki A, et al. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. Cancer 2011; 117:4671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/22\">",
"      Sulman EP, Schwartz DL, Le TT, et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009; 73:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/23\">",
"      Vargo JA, Wegner RE, Heron DE, et al. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck. Head Neck 2012; 34:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/24\">",
"      Milano MT, Vokes EE, Salama JK, et al. Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. Int J Radiat Oncol Biol Phys 2005; 61:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/25\">",
"      Mart&iacute;nez-Monge R, Alcalde J, Concejo C, et al. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study. Brachytherapy 2006; 5:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/26\">",
"      Janot F, de Raucourt D, Benhamou E, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 2008; 26:5518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/27\">",
"      Kasperts N, Slotman BJ, Leemans CR, et al. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. Cancer 2006; 106:1536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/28\">",
"      De Crevoisier R, Domenge C, Wibault P, et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 2001; 91:2071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/29\">",
"      Kasperts N, Slotman B, Leemans CR, Langendijk JA. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol 2005; 41:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/30\">",
"      Biagioli MC, Harvey M, Roman E, et al. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 69:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/31\">",
"      Villaflor VM, Haraf D, Salama JK, et al. Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. Ann Oncol 2011; 22:2501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/32\">",
"      Stevens KR Jr, Britsch A, Moss WT. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994; 29:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/33\">",
"      Goldstein DP, Karnell LH, Yao M, et al. Outcomes following reirradiation of patients with head and neck cancer. Head Neck 2008; 30:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/34\">",
"      Levendag PC, Meeuwis CA, Visser AG. Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. Radiother Oncol 1992; 23:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/35\">",
"      Langlois D, Hoffstetter S, Malissard L, et al. Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin. Int J Radiat Oncol Biol Phys 1988; 14:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/36\">",
"      Peiffert D, Pernot M, Malissard L, et al. Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys 1994; 29:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/37\">",
"      Grimard L, Esche B, Lamothe A, et al. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck 2006; 28:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/38\">",
"      Mazeron JJ, Langlois D, Glaubiger D, et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. Int J Radiat Oncol Biol Phys 1987; 13:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/39\">",
"      Puthawala A, Nisar Syed AM, Gamie S, et al. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results. Int J Radiat Oncol Biol Phys 2001; 51:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/40\">",
"      Hepel JT, Syed AM, Puthawala A, et al. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 62:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/41\">",
"      Perry DJ, Chan K, Wolden S, et al. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 76:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/42\">",
"      Dawson LA, Myers LL, Bradford CR, et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/43\">",
"      Langendijk JA, Kasperts N, Leemans CR, et al. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol 2006; 78:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/44\">",
"      Lee N, Chan K, Bekelman JE, et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 68:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/45\">",
"      Rwigema JC, Heron DE, Ferris RL, et al. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience. Am J Clin Oncol 2010; 33:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/46\">",
"      Nag S, Cano ER, Demanes DJ, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2001; 50:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/47\">",
"      Rate WR, Garrett P, Hamaker R, et al. Intraoperative radiation therapy for recurrent head and neck cancer. Cancer 1991; 67:2738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/48\">",
"      Spencer SA, Harris J, Wheeler RH, et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 2008; 30:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/49\">",
"      Langer CJ, Harris J, Horwitz EM, et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 2007; 25:4800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/50\">",
"      Haraf DJ, Weichselbaum RR, Vokes EE. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 1996; 7:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/51\">",
"      Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001; 51:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/52\">",
"      Chmura SJ, Vokes EE, Garofolo M, et al. Long-term outcome of re-irradiation with concomitant chemotherapy for locally recurrent squamous cell carcinoma of the head and neck (abstract). Int J Radiat Oncol Biol Phys 2003; 57:S409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/53\">",
"      Kramer NM, Horwitz EM, Cheng J, et al. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head Neck 2005; 27:406.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0421 (Accessed on August 22, 2011).",
"    </li>",
"    <li>",
"     Marwaha A, Choong NW, Firat S, et al. Clinical efficacy and tolerability of continuous course reirradiation with concurrent weekly carboplatin-paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head and neck (SCCHN) (abstract #5518). J Clin Oncol 2010; 28:7s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/56\">",
"      Hehr T, Classen J, Belka C, et al. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial. Int J Radiat Oncol Biol Phys 2005; 61:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/57\">",
"      Machtay M, Rosenthal DI, Chalian AA, et al. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 59:72.",
"     </a>",
"    </li>",
"    <li>",
"     Villaflor VM, Cohen EE, Haraf D, et al. Phase II trial pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated head and neck cancer patients. J Clin Oncol 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/59\">",
"      Mabanta SR, Mendenhall WM, Stringer SP, Cassisi NJ. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 1999; 21:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/60\">",
"      Van Waes C, Chang AA, Lebowitz PF, et al. Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2005; 63:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/61\">",
"      Wachsberger P, Burd R, Dicker AP. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin Cancer Res 2003; 9:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/62\">",
"      Seiwert TY, Haraf DJ, Cohen EE, et al. Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer. J Clin Oncol 2008; 26:1732.",
"     </a>",
"    </li>",
"    <li>",
"     Vokes EE, Seiwert TY, Blair E, et al. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer. J Clin Oncol 2008; 26.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/64\">",
"      Kupferman ME, Morrison WH, Santillan AA, et al. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer 2007; 109:2052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/65\">",
"      Cornes PG, Cox HJ, Rhys-Evans PR, et al. Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium-192 brachytherapy and surgical reconstruction. Br J Surg 1996; 83:1620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/66\">",
"      Mendenhall WM, Mendenhall CM, Malyapa RS, et al. Re-irradiation of head and neck carcinoma. Am J Clin Oncol 2008; 31:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/67\">",
"      Le QT, Kim HE, Schneider CJ, et al. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol 2011; 29:2808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/68\">",
"      Henke M, Alfonsi M, Foa P, et al. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 2011; 29:2815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/69\">",
"      McDonald MW, Moore MG, Johnstone PA. Risk of carotid blowout after reirradiation of the head and neck: a systematic review. Int J Radiat Oncol Biol Phys 2012; 82:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/70\">",
"      Upile T, Triaridis S, Kirkland P, et al. The management of carotid artery rupture. Eur Arch Otorhinolaryngol 2005; 262:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/71\">",
"      Bates MC, Shamsham FM. Endovascular management of impending carotid rupture in a patient with advanced head and neck cancer. J Endovasc Ther 2003; 10:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/72\">",
"      Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg 2002; 128:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/73\">",
"      Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma--treatment techniques and results. Int J Radiat Oncol Biol Phys 1987; 13:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/74\">",
"      Wang CC, McIntyre J. Re-irradiation of laryngeal carcinoma--techniques and results. Int J Radiat Oncol Biol Phys 1993; 26:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/75\">",
"      Emami B, Bignardi M, Spector GJ, et al. Reirradiation of recurrent head and neck cancers. Laryngoscope 1987; 97:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/23/38265/abstract/76\">",
"      Tanvetyanon T, Padhya T, McCaffrey J, et al. Prognostic factors for survival after salvage reirradiation of head and neck cancer. J Clin Oncol 2009; 27:1983.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3384 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-2E861B2D37-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38265=[""].join("\n");
var outline_f37_23_38265=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H798962322\">",
"      Patient selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Radioresistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Treatment volume",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Modality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Elective neck treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      POSTOPERATIVE REIRRADIATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      REIRRADIATION FOR UNRESECTABLE RECURRENCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Surgical debulking prior to reirradiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Reirradiation alone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - External beam RT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Brachytherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Intraoperative RT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Reirradiation with concurrent chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - FHX/FHX2 regimens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - FHX2 plus paclitaxel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - FGX2",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Platinum combinations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Induction chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Novel/targeted agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Isolated neck recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PALLIATIVE REIRRADIATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      TOXICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Reirradiation alone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Reirradiation with chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Radioprotectants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Carotid artery injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      PROGNOSTIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/7/17525?source=related_link\">",
"      General principles of radiation therapy for head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/15/29946?source=related_link\">",
"      Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22554?source=related_link\">",
"      Management and prevention of complications of head and neck cancer during initial treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30378?source=related_link\">",
"      Management of late complications of head and neck cancer and its treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/62/28649?source=related_link\">",
"      Methods to overcome radiation resistance in head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/58/15270?source=related_link\">",
"      Second primary malignancies in patients with head and neck cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/3/8250?source=related_link\">",
"      Treatment of early and locoregionally advanced nasopharyngeal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9559?source=related_link\">",
"      Treatment of locally recurrent head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/25/40345?source=related_link\">",
"      Treatment of metastatic and recurrent head and neck cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_23_38266="Ichthyosis vulgaris 2";
var content_f37_23_38266=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61258%7EDERM%2F68882%7EDERM%2F79894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61258%7EDERM%2F68882%7EDERM%2F79894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ichthyosis vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Skin with fine, white, adherent scale is present in this patient with ichthyosis vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ichthyosis vulgaris, sparing of flexural areas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ichthyosis vulgaris. This patient has atopic dermatitis and ichthyosis vulgaris lesions that resemble fish scales. Note the characteristic sparing of the popliteal fossa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ichthyosis vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 348px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This patient with ichthyosis vulgaris has truncal involvement. The appearance resembles fine fish scales.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: George A Datto, III, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38266=[""].join("\n");
var outline_f37_23_38266=null;
var title_f37_23_38267="Criteria for OT and PT in acute hospital setting";
var content_f37_23_38267=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F86416&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F86416&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria to identify patients able to participate in occupational therapy/physical therapy treatment in the acute hospital setting",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"20%\">",
"     </colgroup>",
"     <colgroup span=\"2\" width=\"80%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Health characteristic",
"       </td>",
"       <td class=\"subtitle1\">",
"        Criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Cognition",
"       </td>",
"       <td>",
"        Able to follow one-step commands",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oriented to person",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Remember one of three items",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"7\">",
"        Hemodynamic",
"       </td>",
"       <td>",
"        Mean arterial pressure 65 to 110 mm Hg&nbsp;(resting systolic blood pressure 85 to 160 mm Hg, and &lt;200&nbsp; mm Hg with exertion)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heart rate 40 to 130 beats per min",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respiratory rate 5 to 40 breaths per min",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oxygen saturation &ge;88 percent, with or without supplemental O",
"        <sub>",
"         2",
"        </sub>",
"        and at rest or with activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Change in vital signs with activity &lt;20 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hematocrit &gt;25 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No unstable angina (eg, change in ECG with activity)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Musculoskeletal stability",
"       </td>",
"       <td>",
"        Fracture/open wounds require explicit physician guidance with regards to physical activity (eg, weight-bearing status, orthoses/braces, etc.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"       </td>",
"       <td>",
"        No acute exacerbation of pain during OT/PT",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     OT: occupational therapy; PT: physical therapy; ECG: electrocardiogram.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38267=[""].join("\n");
var outline_f37_23_38267=null;
var title_f37_23_38268="Doses of NMBAs";
var content_f37_23_38268=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adult neuromuscular blocking agents and doses",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Initiation dose, milligrams/kg",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Onset, minutes",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Duration*",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Maintenance dose&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Intermittent injection, milligrams/kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        Continuous infusion, micrograms/kg per minute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atracurium",
"       </td>",
"       <td>",
"        0.4-0.5",
"       </td>",
"       <td>",
"        2-2.5",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"       <td>",
"        0.08-0.1",
"       </td>",
"       <td>",
"        4-12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cisatracurium",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        1.5-2",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"       <td>",
"        0.03",
"       </td>",
"       <td>",
"        1-3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mivacurium&Delta;",
"       </td>",
"       <td>",
"        0.15-0.25",
"       </td>",
"       <td>",
"        1.5-2.5",
"       </td>",
"       <td>",
"        Short",
"       </td>",
"       <td>",
"        0.15-0.25",
"       </td>",
"       <td>",
"        9-10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancuronium",
"       </td>",
"       <td>",
"        0.05-0.1",
"       </td>",
"       <td>",
"        1-3",
"       </td>",
"       <td>",
"        Long",
"       </td>",
"       <td>",
"        0.05-0.1",
"       </td>",
"       <td>",
"        1-2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pipecuronium&Delta;",
"       </td>",
"       <td>",
"        0.085-0.1",
"       </td>",
"       <td>",
"        1.5-3",
"       </td>",
"       <td>",
"        Long",
"       </td>",
"       <td>",
"        0.01-0.015",
"       </td>",
"       <td>",
"        0.5-2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rocuronium",
"       </td>",
"       <td>",
"        0.6-1",
"       </td>",
"       <td>",
"        1-1.5",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        8-12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Succinylcholine&loz;",
"       </td>",
"       <td>",
"        0.3-1.1",
"       </td>",
"       <td>",
"        0.5-1",
"       </td>",
"       <td>",
"        Short",
"       </td>",
"       <td>",
"        0.04-0.07&loz;",
"       </td>",
"       <td>",
"        N/A",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tubocurarine&Delta;",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        1-2",
"       </td>",
"       <td>",
"        Long",
"       </td>",
"       <td>",
"        0.04-0.06",
"       </td>",
"       <td>",
"        2-3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vecuronium",
"       </td>",
"       <td>",
"        0.08-0.1",
"       </td>",
"       <td>",
"        1-1.5",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        0.8-1.2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Duration. Short: approximately 15-20 minutes; Intermediate: approximately 25-60 minutes; Long: approximately 90-100 minutes.",
"     <br>",
"      &bull; Adjust dose to desired clinical response.",
"      <br>",
"       &Delta; Not available in USA.",
"       <br>",
"        &loz; Not recommended for long-term use in the intensive care unit.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38268=[""].join("\n");
var outline_f37_23_38268=null;
var title_f37_23_38269="Contents: Cutaneous lymphoma";
var content_f37_23_38269=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?2/59/3006\">",
"       Dermatology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Cutaneous lymphoma",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Cutaneous lymphoma",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/47/25337\">",
"           Clinical manifestations, pathologic features, and diagnosis of anaplastic large cell lymphoma, ALK positive",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/36/35400\">",
"           Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/23/7546\">",
"           Lymphomatoid papulosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/46/20200\">",
"           Parapsoriasis (small plaque and large plaque parapsoriasis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/6/15464\">",
"           Primary cutaneous follicle center lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/49/26391\">",
"           Primary cutaneous large B cell lymphoma, leg type",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/9/26776\">",
"           Primary cutaneous marginal zone lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/35/36410\">",
"           Treatment of advanced stage (IIB to IV) mycosis fungoides and Szary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/39/17017\">",
"           Treatment of early stage (IA to IIA) mycosis fungoides",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-245BF995DF-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f37_23_38269=[""].join("\n");
var outline_f37_23_38269=null;
var title_f37_23_38270="Epicond eccentric rehab PI";
var content_f37_23_38270=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F81949&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F81949&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Epicondylitis eccentric rehabilitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 321px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photograph demonstrates an eccentric exercise for the wrist extensor muscles. Eccentric exercise involves the application of a load during the lengthening of a muscle and may assist with healing of a tendinopathy. Here the wrist extensors are contracting eccentrically against the resistance of an exercise band.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Neeru Jayanthi, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38270=[""].join("\n");
var outline_f37_23_38270=null;
var title_f37_23_38271="Pocketing";
var content_f37_23_38271=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pocketing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 510px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The ends of the piercing jewelry are embedded into the skin, leaving the middle of the shank exposed, as depicted above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_23_38271=[""].join("\n");
var outline_f37_23_38271=null;
